dc.contributor.author | Cim, Emine Fusun Akyuz | |
dc.contributor.author | Suleyman, Zeynep | |
dc.contributor.author | Suleyman, Halis | |
dc.contributor.author | Yazici, Gulce Naz | |
dc.contributor.author | Coban, Taha Abdulkadir | |
dc.date.accessioned | 2025-01-12T18:54:52Z | |
dc.date.available | 2025-01-12T18:54:52Z | |
dc.date.issued | 2024 | |
dc.identifier.issn | 0362-5664 | |
dc.identifier.issn | 1537-162X | |
dc.identifier.uri | https://doi.org/10.1097/WNF.0000000000000615 | |
dc.identifier.uri | http://hdl.handle.net/11446/4999 | |
dc.description.abstract | Objectives: Our aim was to evaluate the comparative effects of sertraline and vortioxetine against stress-induced brain injury in rats. Methods: The rats were assigned to a nonstress group (NSG), stress-treated control (StC), sertraline + stress (SSt), and vortioxetine + stress (VSt) groups. Sertraline and vortioxetine (10 mg/kg) were given orally by gavage to the SSt and VSt groups. One hour later, all animals (except NSG) underwent forced immobilization to establish a stress model (2 hours). The drugs were given once a day for 30 days. The animals were killed with ketamine 150 mg/kg, and tissues were removed from the cerebral cortex. One-way analysis of variance and Fisher post hoc least significant difference were conducted for the analysis. Results: The malondialdehyde (nmol/mL) level was 2.58 +/- 0.48 in the NSG, 8.09 +/- 0.57 in the StC, 3.84 +/- 0.53 in the SSt, and 2.84 +/- 0.20 in the VSt group (P < 0.0002). The total glutathione (mmol/g) was 7.15 +/- 0.59 in the NSG, 2.41 +/- 0.43 in the StC, 4.58 +/- 0.26 in the SSt, and 5.98 +/- 0.13 in the VSt (P < 0.0002). The total oxidant status (mmol H(2)O(2)Eq/L) level was 3.56 +/- 0.20 in the NSG, 9.99 +/- 0.74 in the StC, 4.97 +/- 0.39 in the SSt, and 3.81 +/- 0.31 in the VSt (P < 0.0002). The total antioxidant status (mmolTroloxEq/L) level was 8.65 +/- 0.37 in the NSG, 3.04 +/- 0.22 in the StC, 6.29 +/- 0.34 in the SSt, and 7.61 +/- 0.40 in the VSt (P < 0.0002). Sertraline reduced pericellular edema in astrocytes and oligodendrocytes and decreased perivascular edema, dilatation, and congestion of blood vessels, whereas these were not seen with vortioxetine. Conclusions: Compared with sertraline, vortioxetine is a neuroprotective antidepressant with higher antioxidant activity and can more effectively prevent stress-induced brain tissue injury. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Lippincott Williams & Wilkins | en_US |
dc.relation.ispartof | Clinical Neuropharmacology | en_US |
dc.identifier.doi | 10.1097/WNF.0000000000000615 | |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | antioxidant | en_US |
dc.subject | brain injury | en_US |
dc.subject | oxidant | en_US |
dc.subject | oxidative stress | en_US |
dc.subject | sertraline | en_US |
dc.subject | stress | en_US |
dc.subject | vortioxetine | en_US |
dc.subject | Major Depressive Disorder | en_US |
dc.subject | Oxidative Stress | en_US |
dc.subject | Antidepressant Drugs | en_US |
dc.subject | Improves | en_US |
dc.subject | Liver | en_US |
dc.title | Effect of Sertraline and Vortioxetine on Stress-Induced Brain Injury in Rats: Biochemical and Histopathological Evaluations | en_US |
dc.type | review | en_US |
dc.department | DBÜ | en_US |
dc.identifier.issue | 6 | en_US |
dc.identifier.volume | 47 | en_US |
dc.identifier.startpage | 213 | en_US |
dc.identifier.endpage | 217 | en_US |
dc.relation.publicationcategory | Diğer | en_US |
dc.department-temp | [Cim, Emine Fusun Akyuz] Demiroglu Bilim Univ, Med Fac, Florence Nightingale Hosp, Dept Psychiat, Abide I Hurriyet Cd 166, TR-34381 Istanbul, Turkiye; [Suleyman, Zeynep] Erzincan Binali Yildirim Univ, Fac Hlth Sci, Dept Nursing, Erzincan, Turkiye; [Suleyman, Halis] Erzincan Binali Yildirim Univ, Fac Med, Dept Pharmacol, Erzincan, Turkiye; [Yazici, Gulce Naz] Erzincan Binali Yildirim Univ, Fac Med, Dept Histol & Embryol, Erzincan, Turkiye; [Coban, Taha Abdulkadir] Erzincan Binali Yildirim Univ, Fac Med, Dept Med Biochem, Erzincan, Turkiye | en_US |
dc.identifier.scopus | 2-s2.0-85210353288 | en_US |
dc.identifier.wos | WOS:001361328000002 | en_US |
dc.authorscopusid | 57193327183 | |
dc.authorscopusid | 56523253700 | |
dc.authorscopusid | 35493298200 | |
dc.authorscopusid | 57208241141 | |
dc.authorscopusid | 6603745281 | |